Orphan Drug Development: Overcoming Manufacturing Challenges
How a rare disease company navigated unique manufacturing challenges for an orphan drug.
1 min read686 viewsPublished September 15, 2025
Orphan Drug Development: Overcoming Manufacturing Challenges
The Context
Developing medications for rare diseases presents unique manufacturing challenges due to small patient populations and limited commercial volumes.
Specific Challenges
- Very small batch sizes needed
- Limited economies of scale
- Specialized formulation requirements
- Complex regulatory pathway
Strategic Approach
CDMO Selection Criteria
- Experience with small-volume production
- Flexible manufacturing capabilities
- Regulatory expertise in orphan drugs
Manufacturing Strategy
- Dedicated equipment allocation
- Multi-product facility considerations
- Specialized containment for potent compounds
Key Outcomes
- Successfully launched in 12 months
- Cost-effective small-batch production
- Regulatory approvals in US and EU
Insights for Others
- Partner with CDMOs experienced in orphan drugs
- Plan for regulatory complexities early
- Consider long-term supply strategy
Was this article helpful?
Sign in to provide feedback